On 12/9/24, Agios Pharmaceuticals Inc (NASDAQ: AGIO) stock suffered a major decline of -21.1%, closing at $48.64. Moreover, trading volume in this decline was exceptionally high at 483% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -18.1% during the last week.
Current PriceTarget Research Rating
Agios Pharmaceuticals has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Agios Pharmaceuticals has a poor Appreciation Score of 16 but a very high Power Rating of 90, and the Neutral Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment